Literature DB >> 3318637

Mustard gas: clinical, toxicological, and mutagenic aspects based on modern experience.

A Aasted1, E Darre, H C Wulf.   

Abstract

Based on a study of the literature and our own experience treating fisherman poisoned by mustard gas, this article outlines the clinical effects, and toxicological and mutagenic properties of the agent. Mustards are very persistent chemical agents that easily penetrate clothing. Mustard gas usually causes clinical symptoms after the liquid penetrates the skin or the vapor is inhaled. Skin lesions are similar to first- or second-degree burns and usually heal spontaneously in 4 to 6 weeks. Eye symptoms are photophobia and reduced vision. Following inhalation of the agent, pulmonary edema and long-term dyspnea may be seen. As mustard gas is an alkylating substance, it is conceivable that the risk of developing cancer may be increased, as observed in people who were involved with the production of mustard gas and in animals exposed to the gas. Also, transient significantly increased sister chromatid exchange rates have been found in fishermen exposed to mustard gas. Patients exposed to mustard gas must be treated immediately after exposure. Treatment should consist of cleaning of the exposed skin and clothes with an antigas powder and water and soap. The skin lesions should be treated as burns. Eye lesions and respiratory problems should be treated symptomatically.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3318637

Source DB:  PubMed          Journal:  Ann Plast Surg        ISSN: 0148-7043            Impact factor:   1.539


  13 in total

1.  A recent exposure to mustard gas in the United States: clinical findings of a cohort (n = 247) 6 years after exposure.

Authors:  Yuruk Iyriboz
Journal:  MedGenMed       Date:  2004-10-22

2.  Relationship between eosinophilia and levels of chemokines (CCL5 and CCL11) and IL-5 in bronchoalveolar lavage fluid of patients with mustard gas-induced pulmonary fibrosis.

Authors:  Ali Emad; Yasaman Emad
Journal:  J Clin Immunol       Date:  2007-06-28       Impact factor: 8.317

3.  Relationship between eosinophilia and levels of chemokines (CCL5 and CCL11) and IL-5 in bronchoalveolar lavage fluid of patients with mustard gas-induced pulmonary fibrosis.

Authors:  Ali Emad; Yasaman Emad
Journal:  J Clin Immunol       Date:  2007-07-10       Impact factor: 8.317

Review 4.  Mustard vesicant-induced lung injury: Advances in therapy.

Authors:  Barry Weinberger; Rama Malaviya; Vasanthi R Sunil; Alessandro Venosa; Diane E Heck; Jeffrey D Laskin; Debra L Laskin
Journal:  Toxicol Appl Pharmacol       Date:  2016-05-19       Impact factor: 4.219

5.  Capsaicinoids, chloropicrin and sulfur mustard: possibilities for exposure biomarkers.

Authors:  Maija Pesonen; Kirsi Vähäkangas; Mia Halme; Paula Vanninen; Heikki Seulanto; Matti Hemmilä; Markku Pasanen; Tapio Kuitunen
Journal:  Front Pharmacol       Date:  2010-12-20       Impact factor: 5.810

Review 6.  Synthetic high-density lipoprotein nanoparticles: Good things in small packages.

Authors:  Robert M Lavker; Nihal Kaplan; Kaylin M McMahon; Andrea E Calvert; Stephen E Henrich; Ummiye V Onay; Kurt Q Lu; Han Peng; C Shad Thaxton
Journal:  Ocul Surf       Date:  2021-04-21       Impact factor: 6.268

Review 7.  Ocular toxicity of mustard gas: A concise review.

Authors:  Allison Fuchs; Elizabeth A Giuliano; Nishant R Sinha; Rajiv R Mohan
Journal:  Toxicol Lett       Date:  2021-02-15       Impact factor: 4.271

Review 8.  Hazards of chemical weapons release during war: new perspectives.

Authors:  S Reutter
Journal:  Environ Health Perspect       Date:  1999-12       Impact factor: 9.031

9.  Teratogenic effects of sulfur mustard on mice fetuses.

Authors:  Nasrin Sanjarmoosavi; Naser Sanjarmoosavi; Marziyeh Shahsavan; Mohammad Hassanzadeh-Nazarabadi
Journal:  Iran J Basic Med Sci       Date:  2012-05       Impact factor: 2.699

10.  Cleft Palate induced by Sulfur Mustard in mice fetus.

Authors:  Mohammad Hassanzadeh-Nazarabadi; Nasrin Sanjarmoosavi; Naser Sanjarmoosavi; Sahar Shekouhi
Journal:  Int J Mol Cell Med       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.